Raise In Debt Ceiling Means FDA Funding Bill Can Advance

The US House on 25 July signed off on a two-year budget deal for FY 2020 and 2021 raising the federal debt ceiling, and allowing funding for FDA and other federal agencies to go forward.

Debt-ceiling

The US Senate and House this week reached an agreement with the White House to suspend federal government spending limits and raise the debt ceiling, giving a green light for a US Food and Drug Administration appropriations bill to advance.

The House approved its FDA funding bill earlier this summer, giving the agency an overall increase of 6% for FY...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Legislation

More from Policy & Regulation

UK Healthtech Center Of Excellence Given Key MHRA Digital Regulation Role

 
• By 

Ahead of the 11 June UK spending review and its anticipated funding uplift for healthcare and life sciences, the MHRA announced an expansion of its digital expertise by creating a dedicated hub in Leeds, a renowned center of medtech excellence.

‘Small Business’ Applications For Waiver Of Device User Fees To Be Streamlined By US FDA

 

FDA moves forward with implementing previous draft guidance and will consolidate forms, but the agency estimates limited impact in the total reporting burden.

FDA Outlines Responsibilities For Owners Of Transferred 510(k)s

 
• By 

The US FDA's new draft guidance details the responsibilities of new owners of 510(k) clearances, including making timely updates device listings in FURLS and GUDID to maintain accurate information for safety alerts and recalls. Comments on the draft are accepted until 4 August.